Filters

See more specimen types...

Other countries

Results: 1 to 20 of 35 (representing 13 labs)

Tests names and labsConditionsGenes and analytesMethods

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
4062
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Centogene AG - the Rare Disease Company
Germany
4688
  • E Sequence analysis of select exons

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • -- Deletion/duplication analysis
  • -- Sequence analysis of the entire coding region

Invitae Pediatric Solid Tumors Panel

Invitae
United States
9148
  • -- Deletion/duplication analysis
  • -- Sequence analysis of the entire coding region

ONCOLOGY, PANEL

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
6780
  • C Sequence analysis of the entire coding region

Prostate Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ovarian Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Endometrial Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5814
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Focus Cancer Panel - 40 Genes

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5640
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer Panel

Invitae
United States
14180
  • -- Deletion/duplication analysis
  • -- Sequence analysis of the entire coding region

Single gene testing PTCH2

CeGaT GmbH
Germany
31
  • C Sequence analysis of the entire coding region

Inherited Cancer Panel

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health and Science University
United States
3349
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Capillary Malformation-Arteriovenous Malformation Syndrome Test

Invitae
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PTCH1 Gene Sequencing

DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
31
  • C Sequence analysis of the entire coding region

Hemato-oncology chromosomal microarray

Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center
United States
2393
  • H Detection of homozygosity
  • D Deletion/duplication analysis
  • H Detection of homozygosity

Single gene testing PTCH1

CeGaT GmbH
Germany
31
  • C Sequence analysis of the entire coding region

Brain, CNS, and PNS Cancer: Sequencing and Deletion/Duplication Panel

Emory Genetics Laboratory Emory University School of Medicine
United States
1516
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 35

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center